Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- AMSC +18.6%, RMD +8.8%, NOK +8.2%, NTCT +7.9%, IBM +7.3%, TAL +6.8%, AAL +4.8%, URI +4% (also intends to repurchase $1.5 bln in 2024 and intends to raise dividend by 10%), BX +3.2%, LVS +3.1%, CMCSA +2.2%, NFBK +1.9%, CNX +1.8%, NEE +1.8%, LUV +1.6%, EXP +1.5%, CCI +1.4% (also says CFO will remain), WRB +1.4%, VLO +1.4%, RES +1.4%, NEP +1.4%, ALK +1.1%, MKC +1.1%, MBLY +0.9%, LRCX +0.7%, NOW +0.5% (also announces alliance with Visa to transform payment services)
Other news:
- VERA +11.3% (announced positive 72-week data from the open label extension (OLE) period of its Phase 2b ORIGIN clinical trial of atacicept in participants with IgA nephropathy)
- TIGR +5.3% (Announces Uplift of Type 1 License by Hong Kong SFC to include Virtual Asset dealing service for Professional Investors)
- INGN +3.2% (names new CFO)
- ADT +2.1% (exits residential solar business increases dividend by 57% authorizes $350 mln repurchase plan) SSL +2.1% (Production)
- KAI +1.3% (acquires KWS Manufacturing)
- HLN +1.1% (divests ChapStick)
- SAVE +1% (announces convertible note adjustments)
Analyst comments:
- ALTI +6.2% (upgraded to Strong Buy from Mkt Perform at Raymond James)
- RDCM +3.2% (upgraded to Buy from Hold at Needham)
- CAR +2.6% (upgraded to Buy from Hold at Deutsche Bank)
- HEI +1.6% (upgraded to Buy from Neutral at BofA Securities)
- NFLX +0.9% (upgraded to Buy from Hold at DZ Bank)
- RTX +0.9% (upgraded to Neutral from Underperform at BofA Securities)